Vimarsana
Biggest News Aggregation in the World

Page 7 - Malik Peiris News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Malik Peiris. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Malik Peiris Today - Breaking & Trending Today

Third dose of Sinovac vaccine insufficient against omicron: Study - Vimarsana News

Third dose of Sinovac vaccine insufficient against omicron: Study

Contradicting the vaccine maker's pronouncement, a new study has found that a third dose of Sinovac's Covid-19 vaccine does not provide sufficient protection against the Omicron variant.

Source: india.com
Third dose of Sinovac vax insufficient against omicron: Study - Vimarsana News

Third dose of Sinovac vax insufficient against omicron: Study

Contradicting the vaccine maker's pronouncement, a new study has found that a third dose of Sinovac's Covid-19 vaccine does not provide sufficient protection against the Omicron variant.According to Nikkei Asia, the University of Hong Kong ...

Study finds 3rd dose of China's Sinovac ineffective against Omicron | Taiwan News - Vimarsana News

Study finds 3rd dose of China's Sinovac ineffective against Omicron | Taiwan News

Researchers recommend Sinovac recipients take BNT booster to protect against Omicron | 2021-12-24 12:49:00

Three Sinovac doses fail to protect against Omicron in study - Vimarsana News

Three Sinovac doses fail to protect against Omicron in study

Two doses and a booster of the Covid-19 vaccine made by China’s Sinovac Biotech Ltd, one of the most widely used in the world, didn’t produce sufficient levels of neutralising antibodies to protect against the Omicron variant, a laboratory study found.

2.3bn Covid shots useless against Omicron study - Vimarsana News

2.3bn Covid shots useless against Omicron study

A Chinese study has revealed that the vaccine made by China?s Sinovac Biotech fails to provide adequate protection against the Omicron variant of Covid-19